• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症中的肺部受累

Lung involvement in systemic sclerosis.

作者信息

Silver R M, Miller K S

机构信息

Medical University of South Carolina, Charleston.

出版信息

Rheum Dis Clin North Am. 1990 Feb;16(1):199-216.

PMID:2406808
Abstract

The lungs are frequently affected in systemic sclerosis, and pulmonary disease may significantly influence morbidity and mortality. The clinical, radiographic, and physiologic features of scleroderma lung disease are discussed in this article, as are new approaches to the detection and study of interstitial pneumonitis. The pathogenesis of pulmonary fibrosis is discussed in the context of data derived from bronchoalveolar lavage studies. Pulmonary vascular disease and less common pulmonary features of systemic sclerosis are also discussed.

摘要

系统性硬化症常累及肺部,肺部疾病可能会显著影响发病率和死亡率。本文讨论了硬皮病肺部疾病的临床、影像学和生理学特征,以及间质性肺炎检测和研究的新方法。在支气管肺泡灌洗研究数据的背景下,讨论了肺纤维化的发病机制。还讨论了系统性硬化症的肺血管疾病和较少见的肺部特征。

相似文献

1
Lung involvement in systemic sclerosis.系统性硬化症中的肺部受累
Rheum Dis Clin North Am. 1990 Feb;16(1):199-216.
2
[Pulmonary changes in progressive systemic sclerosis].
Zhonghua Jie He He Hu Xi Za Zhi. 1990 Jun;13(3):157-9, 191.
3
[Pulmonary involvement in sclerodermia].[硬皮病中的肺部受累]
Minerva Med. 1994 Jun;85(6):293-300.
4
Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.系统性硬化症中心脏和肺部受累的非侵入性诊断及功能评估
In Vivo. 2004 Mar-Apr;18(2):229-35.
5
Pulmonary functions in children with progressive systemic sclerosis.
Pediatrics. 1991 Dec;88(6):1161-7.
6
Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.炎症在系统性硬化症肺部疾病中的作用:与特发性肺纤维化的比较。
J Lab Clin Med. 1986 Mar;107(3):253-60.
7
Pulmonary manifestations of scleroderma and mixed connective tissue disease.硬皮病和混合性结缔组织病的肺部表现。
Clin Chest Med. 2010 Sep;31(3):433-49. doi: 10.1016/j.ccm.2010.05.004.
8
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.系统性硬化症合并活动性肺泡炎患者呼吸困难程度与健康相关生活质量、功能能力及一氧化碳弥散能力的相关性:硬皮病肺部研究结果
Arthritis Rheum. 2005 Feb;52(2):592-600. doi: 10.1002/art.20787.
9
[Cardiac and pulmonary involvement in scleroderma].[硬皮病中的心脏和肺部受累]
Rev Prat. 2002 Nov 1;52(17):1901-7.
10
[Possible connection between gastroesophageal reflux and interstitial pulmonary fibrosis in patients with systemic sclerosis].[系统性硬化症患者胃食管反流与间质性肺纤维化之间的可能联系]
Recenti Prog Med. 2009 Nov;100(11):512-6.

引用本文的文献

1
Imaging lung disease in systemic sclerosis.系统性硬化症的肺部影像学表现。
Curr Rheumatol Rep. 2010 Apr;12(2):156-61. doi: 10.1007/s11926-010-0095-0.
2
Patterns of pulmonary function in smoking and nonsmoking patients with progressive systemic sclerosis.吸烟和不吸烟的进行性系统性硬化症患者的肺功能模式。
Rheumatol Int. 2009 Jul;29(9):995-9. doi: 10.1007/s00296-008-0824-0. Epub 2009 Jan 8.
3
Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.
系统性硬化症患者支气管肺泡灌洗液、外周血及皮肤中单核炎性细胞、CD4/CD8⁺ T细胞、白细胞介素1β和肿瘤坏死因子α的变化
J Clin Pathol. 2005 Feb;58(2):178-84. doi: 10.1136/jcp.2004.019224.
4
Predictors of end stage lung disease in a cohort of patients with scleroderma.一组硬皮病患者中终末期肺病的预测因素
Ann Rheum Dis. 2003 Feb;62(2):146-50. doi: 10.1136/ard.62.2.146.
5
Imaging of the pulmonary manifestations of systemic disease.系统性疾病肺部表现的影像学检查
Postgrad Med J. 2001 Oct;77(912):621-38. doi: 10.1136/pmj.77.912.621.
6
Spontaneous pneumothorax in a patient with systemic sclerosis.
Clin Rheumatol. 1996 Mar;15(2):211-3. doi: 10.1007/BF02230345.